The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness of anlotinib in combination with PD-1 inhibitors as second-line or later therapy for advanced or metastatic esophageal squamous cell carcinoma.
 
Yonggui Hong
No Relationships to Disclose
 
Tao Wu
No Relationships to Disclose
 
Ping Lu
No Relationships to Disclose
 
Zhiwei Chang
No Relationships to Disclose
 
Wei Liang
No Relationships to Disclose
 
Guifang Zhang
No Relationships to Disclose
 
Junsheng Wang
No Relationships to Disclose